Comments: SD SB163 | 2022 | Regular Session

Bill Title: Address transparency in prescription drug pricing.

Spectrum: Moderate Partisan Bill (Republican 13-2)

Status: (Introduced - Dead) 2022-02-23 - Senate Reconsidered, Failed, YEAS 16, NAYS 19. S.J. 372 [SB163 Detail]

Text: Latest bill text (Comm Sub) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 South Dakota SB163 at this time.

Social Comments on SD SB163

feedback